RxDoctor Payments Data

Sherri Thomas

Internal Medicine · Lincoln, NENPI 1215107826

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $121,725 of the $135,805 with a category attached, or 89.6%. Novo Nordisk accounts for 99.2% of it on its own, with 11 other manufacturers making up the rest. Among internal medicine clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$135,805in general payments, 2019–2025

Across 144 payments — averaging $943.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$135K
  • Boston Scientific$280
  • Echosens North America, Inc.$230
  • Corcept Therapeutics$143
  • AbbVie$118
  • Janssen Scientific Affairs, LLC$105
  • plus $149 from 6 others

What the payments were for

  • Speaking & faculty fees$121,72590%
  • Travel & lodging$10,0897%
  • Food & beverage$3,9273%
  • Education$650%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$135,805 in reported general payments places this provider in the 95th percentile of 570 internal medicine providers in Nebraska.

See all internal medicine providers in Nebraska

Other internal medicine in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →